Gene: MTCH1
Official Full Name: mitochondrial carrier 1provided by HGNC
Gene Summary: This gene encodes a member of the mitochondrial carrier family. The encoded protein is localized to the mitochondrion inner membrane and induces apoptosis independent of the proapoptotic proteins Bax and Bak. Pseudogenes on chromosomes 6 and 11 have been identified for this gene. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Oct 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05469 | MTCH1 Knockout cell line (HeLa) | Human | MTCH1 | 1:3~1:6 | Negative | Online Inquiry |
KO05470 | MTCH1 Knockout cell line (HCT 116) | Human | MTCH1 | 1:2~1:4 | Negative | Online Inquiry |
KO05471 | MTCH1 Knockout cell line (HEK293) | Human | MTCH1 | 1:3~1:6 | Negative | Online Inquiry |
KO05472 | MTCH1 Knockout cell line (A549) | Human | MTCH1 | 1:3~1:4 | Negative | Online Inquiry |
MTCH1 Gene Knockout Cell Lines are genetically engineered cellular models designed to specifically disrupt the function of the mitochondrial carrier protein MTCH1, which plays a pivotal role in mitochondrial dynamics and apoptosis. By utilizing CRISPR-Cas9 technology, these cell lines contain targeted mutations that inhibit MTCH1 gene expression. This results in a robust system to study the consequences of loss-of-function in MTCH1, thereby enabling researchers to gain deeper insights into mitochondrial biology and related cellular processes.
The main functions of MTCH1 include its involvement in mitochondrial membrane stability and mediating apoptosis through the intrinsic pathway. Such knockout cell lines serve as powerful tools for elucidating the mechanisms by which cellular stress affects mitochondrial integrity and how this relates to diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. They allow for the assessment of metabolic changes, reactive oxygen species (ROS) production, and altered apoptosis rates, which are critical for understanding the pathophysiology of various diseases.
The scientific importance of MTCH1 Gene Knockout Cell Lines is underscored by their applications in both research and clinical settings. They facilitate high-throughput screening for potential therapeutic compounds that can restore mitochondrial function or inhibit pathways leading to cell death. Understanding MTCH1’s role may also open avenues for personalized medicine approaches, particularly in targeting metabolic disorders.
What sets our MTCH1 Gene Knockout Cell Lines apart from alternatives is their high fidelity and efficiency of gene editing, ensuring a consistent and reproducible model. Unlike traditional knockdown approaches, which may leave residual gene expression, our knockout lines provide unequivocal evidence of the complete loss of function, offering clearer insights into the gene's role.
For researchers and clinicians focusing on mitochondrial function and its implications in health and disease, these cell lines represent a valuable asset. The precise gene editing capabilities and the cellular relevance of our model ensure that you can trust it will yield scientifically robust results.
Our company prides itself on delivering high-quality biological tools backed by extensive expertise in genetic engineering and cell culture. We are committed to empowering the scientific community with innovative products that support groundbreaking research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.